Skip to main content
Signal8

Bianco James A.

SEC insider (Form 3/4/5 filer). CIK 0001198554. Chief Executive Officer at TuHURA Biosciences, Inc./NV (HURA). 5 reported Form 4/5 transactions since Sep 2024; latest on May 28, 2026. Located in TAMPA, FL.

Companies Bianco James A. has filed insider reports for

  • TuHURA Biosciences, Inc./NV (HURA): Director, Officer, Chief Executive Officer
Bianco James A. profile photo

Bianco James A.

CIK: 0001198554

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)4 (80.0%)

Compensation grants

Other (G, F, J, C, D, …)1 (20.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

TuHURA Biosciences, Inc./NV logo
HURA

TuHURA Biosciences, Inc./NV

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (5 total)

  • TuHURA Biosciences, Inc./NV logo
    HURA

    TuHURA Biosciences, Inc./NV

    May 28, 2026
    Gift
    Direct
    150K shares-
  • TuHURA Biosciences, Inc./NV logo
    HURA

    TuHURA Biosciences, Inc./NV

    Jan 6, 2026
    Award

    Options (Right to Buy)

    Direct
    610.3K shares-
  • TuHURA Biosciences, Inc./NV logo
    HURA

    TuHURA Biosciences, Inc./NV

    Dec 12, 2025
    Award

    Options (Right to Buy)

    Direct
    3.4M shares-
  • TuHURA Biosciences, Inc./NV logo
    HURA

    TuHURA Biosciences, Inc./NV

    Nov 12, 2024
    Award

    Options (Right to Buy)

    Direct
    1.1M shares-
  • Kintara Therapeutics, Inc. logo
    KTRA

    Kintara Therapeutics, Inc.

    Oct 18, 2024
    Award
    Direct
    2.3M shares-

1-5 of 5